Results 81 to 90 of about 22,744 (213)

Personalised treatment of patients with advanced ovarian cancer: comparative analysis of surgical approaches

open access: yesJournal of Education, Health and Sport
The authors analysed the results of treatment of patients with advanced ovarian cancer depending on the surgical approach used and the results of NIRES application.
A. Rybin   +3 more
doaj   +1 more source

Complete elimination of hyperleukocytosis risk in AML through early high-quality disease remission

open access: yesFrontiers in Oncology
BackgroundAcute myeloid leukemia (AML) with hyperleukocytosis (HL) is a severe medical emergency associated with high mortality rates and poor prognosis. Prompt and urgent treatment is crucial to address this medical emergency.
Guoqing Lyu   +4 more
doaj   +1 more source

Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review [PDF]

open access: gold, 2022
Antonio Sommariva   +14 more
openalex   +1 more source

Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours

open access: yesClinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Evidence suggests NOTCH activation is among the survival and proliferation pathways interacting with FOXL2 c.402C > G (p.Cys134Trp) mutation in granulosa cell tumours (GCT). This Phase II clinical trial of nirogacestat in GCT achieved its enrolment target in < 1 year and primary analysis within 2 years.
Rachel N. Grisham   +20 more
wiley   +1 more source

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)

open access: yesCurrent Oncology
Multidisciplinary strategies have transformed the management of advanced ovarian cancer. We aimed to evaluate the effectiveness of paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) following surgical cytoreduction for ovarian peritoneal ...
Pedro Villarejo Campos   +8 more
doaj   +1 more source

THE VALUE OF CYTOREDUCTIVE SURGERY FOR ISOLATED LYMPH NODE RECURRENCE OF OVARIAN CANCER

open access: yesСибирский онкологический журнал, 2020
The purpose of the study was to undertake a systematic literature review regarding the role of cytoreductive surgery in treatment of recurrent ovarian cancer, as well as to summarize available data on various current studies and estimate indications for ...
H. I. Mamajonov   +2 more
doaj   +1 more source

Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 215-222, January 2026.
Abstract Objective To compare overall survival (OS) in patients with high‐grade serous ovarian cancer (HGSOC) treated with intraperitoneal (IP) chemotherapy versus intravenous (IV) chemotherapy. Methods A retrospective study of Stage III HGSOC with optimal primary cytoreduction during 2007–2019, followed by adjuvant IP or IV chemotherapy.
Joshua S Cheruvathur   +7 more
wiley   +1 more source

TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE SKIN WITH THE USE OG CRYOGENIC TECHNOLOGIES

open access: yesСибирский онкологический журнал, 2020
Background. The incidence of skin cancer has been steadily increasing worldwide. Squamous cell skin carcinoma (SCSC ) is the second most common form of epithelial cancer.
O. I. Baykalova   +3 more
doaj   +1 more source

Detection of monosomy 7 in interphase cells of patients with myeloid disorders [PDF]

open access: yes, 1990
Six patients, five with acute myeloid leukemia (AML) and one with a myelodysplastic syndrome (MDS), were found to have monosomy 7 by conventional cytogenetics at diagnosis.
Cremer, Thomas   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy